Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorte Bek

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal of Clinical Microbiology|March 1, 2013
Can molecular methods detect 1% isoniazid resistance in Mycobacterium tuberculosis?Dorte Bek Folkvardsen, Erik Svensson, Vibeke Ø Thomsen, et al.
Journal of Clinical Microbiology|April 20, 2026
Seven decades of nontuberculous mycobacteria in Denmark: shifts in species distribution and clinical relevanceXenia Emilie Sinding Iversen, Anders Norman, Dorte Bek Folkvardsen, et al.
Tuberculosis Research and Treatment|April 19, 2021
Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International LaboratoryDaria N Podlekareva, Dorte Bek Folkvardsen, Alena Skrahina, et al.
Journal of Clinical Microbiology|September 27, 2013
Rifampin heteroresistance in Mycobacterium tuberculosis cultures as detected by phenotypic and genotypic drug susceptibility test methodsDorte Bek Folkvardsen, Vibeke Ø Thomsen, Leen Rigouts, et al.
The European Respiratory Journal|April 20, 2013
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative studyWouter Hoefsloot, Jakko van Ingen, Claire Andrejak, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of Clinical Microbiology|March 1, 2013
Can molecular methods detect 1% isoniazid resistance in Mycobacterium tuberculosis?Dorte Bek Folkvardsen, Erik Svensson, Vibeke Ø Thomsen, et al.
Journal of Clinical Microbiology|April 20, 2026
Seven decades of nontuberculous mycobacteria in Denmark: shifts in species distribution and clinical relevanceXenia Emilie Sinding Iversen, Anders Norman, Dorte Bek Folkvardsen, et al.
Tuberculosis Research and Treatment|April 19, 2021
Tuberculosis Drug Susceptibility, Treatment, and Outcomes for Belarusian HIV-Positive Patients with Tuberculosis: Results from a National and International LaboratoryDaria N Podlekareva, Dorte Bek Folkvardsen, Alena Skrahina, et al.
Journal of Clinical Microbiology|September 27, 2013
Rifampin heteroresistance in Mycobacterium tuberculosis cultures as detected by phenotypic and genotypic drug susceptibility test methodsDorte Bek Folkvardsen, Vibeke Ø Thomsen, Leen Rigouts, et al.
The European Respiratory Journal|April 20, 2013
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative studyWouter Hoefsloot, Jakko van Ingen, Claire Andrejak, et al.
Pageof 3